NASDAQ:RDNT RadNet (RDNT) Stock Price, News & Analysis $53.36 +0.83 (+1.58%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$52.54 -0.83 (-1.55%) As of 08/8/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About RadNet Stock (NASDAQ:RDNT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RadNet alerts:Sign Up Key Stats Today's Range$52.60▼$54.1150-Day Range$52.53▼$59.2952-Week Range$45.00▼$93.65Volume1.55 million shsAverage Volume692,750 shsMarket Capitalization$4.00 billionP/E RatioN/ADividend YieldN/APrice Target$69.60Consensus RatingStrong Buy Company Overview RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. Read More RadNet Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreRDNT MarketRank™: RadNet scored higher than 85% of companies evaluated by MarketBeat, and ranked 146th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingStrong Buy Consensus RatingRadNet has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageRadNet has only been the subject of 1 research reports in the past 90 days.Read more about RadNet's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-5.36% Earnings GrowthEarnings for RadNet are expected to decrease by -5.36% in the coming year, from $0.56 to $0.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is -124.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is -124.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRadNet has a P/B Ratio of 3.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about RadNet's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.64% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 9.6.Change versus previous monthShort interest in RadNet has recently decreased by 1.97%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Sustainability and ESG4.6 / 5Environmental Score-0.52 Percentage of Shares Shorted8.64% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 9.6.Change versus previous monthShort interest in RadNet has recently decreased by 1.97%, indicating that investor sentiment is improving. News and Social Media3.2 / 5News Sentiment0.84 News SentimentRadNet has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for RadNet this week, compared to 7 articles on an average week.MarketBeat Follows4 people have added RadNet to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,613,220.00 in company stock.Percentage Held by InsidersOnly 5.60% of the stock of RadNet is held by insiders.Percentage Held by Institutions77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about RadNet's insider trading history. Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address RDNT Stock News HeadlinesRadNet, Inc. Reports 8.4% Revenue Growth and Record Adjusted EBITDA in Q2 20252 hours ago | quiverquant.comQRadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges2 hours ago | globenewswire.comBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMOLISHED Google's record using pure light particles instead of exotic superconductors. The secret? A revolutionary material that ONE American company is the first to commercially produce.August 10 at 2:00 AM | The Oxford Club (Ad)Earnings To Watch: RadNet Inc (RDNT) Reports Q2 2025 ResultAugust 10 at 2:39 AM | finance.yahoo.comRadNet (RDNT) Reports Q2: Everything You Need To Know Ahead Of EarningsAugust 9 at 4:21 AM | msn.comRadNet, Inc. (NASDAQ:RDNT) Given Average Rating of "Strong Buy" by AnalystsAugust 9 at 2:57 AM | americanbankingnews.comRadNet (RDNT) Expected to Announce Quarterly Earnings on SundayAugust 9 at 2:11 AM | americanbankingnews.comDeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™August 7 at 6:31 PM | finance.yahoo.comSee More Headlines RDNT Stock Analysis - Frequently Asked Questions How have RDNT shares performed this year? RadNet's stock was trading at $69.84 on January 1st, 2025. Since then, RDNT shares have decreased by 23.6% and is now trading at $53.36. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) issued its quarterly earnings data on Thursday, February, 27th. The medical research company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.01. The medical research company had revenue of $477.10 million for the quarter, compared to analysts' expectations of $459.42 million. RadNet had a negative net margin of 1.73% and a positive trailing twelve-month return on equity of 1.41%. Read the conference call transcript. Who are RadNet's major shareholders? Top institutional investors of RadNet include Allspring Global Investments Holdings LLC (2.40%), Geode Capital Management LLC (2.19%), Emerald Advisers LLC (0.90%) and Global Alpha Capital Management Ltd. (0.84%). Insiders that own company stock include Alma Gregory Sorensen, Norman R Hames, Ranjan Jayanathan, David L Swartz, Lawrence L Levitt, Mark Stolper, David Jeffrey Katz, Cornelis Wesdorp, Michael N Murdock, Christine Nayoma Gordon and Gregory E Spurlock. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some other companies that RadNet investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Broadcom (AVGO) and Palo Alto Networks (PANW). Company Calendar Last Earnings2/27/2025Today8/10/2025Next Earnings (Estimated)8/10/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:RDNT CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees11,021Year Founded1980Price Target and Rating Average Price Target for RadNet$69.60 High Price Target$80.00 Low Price Target$60.00 Potential Upside/Downside+30.4%Consensus RatingStrong Buy Rating Score (0-4)3.50 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.43) Trailing P/E RatioN/A Forward P/E Ratio95.29 P/E GrowthN/ANet Income$2.79 million Net Margins-1.73% Pretax Margin0.44% Return on Equity1.41% Return on Assets0.48% Debt Debt-to-Equity Ratio0.87 Current Ratio2.01 Quick Ratio2.01 Sales & Book Value Annual Sales$1.83 billion Price / Sales2.19 Cash Flow$3.48 per share Price / Cash Flow15.32 Book Value$15.31 per share Price / Book3.49Miscellaneous Outstanding Shares75,030,000Free Float70,828,000Market Cap$4.00 billion OptionableOptionable Beta1.43 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:RDNT) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.